Clinical Trial Update: FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial investigates FACBC PET and PEM as staging tools and indicators of therapeutic response in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FACBC PET
• PEM

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | EARLY_Phase 1 | Status: COMPLETED